| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.88▲ | 9.81▲ | 9.81▲ | 9.64▲ | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
| ▲ GAP | $LLYZ Open Gap Up %2 | Set Alert |
|
Monday, December 08, 2025 09:36 AM
Eli Lilly and Company (NYSE:LLY) is included among the 14 Best US Stocks to Buy for Long Term. On December 3, Guggenheim raised its price target on Eli Lilly and Company (NYSE:LLY) to $1,163 from ...
|
|
Monday, December 08, 2025 09:18 AM
Lilly reports Phase 3 CLL results showing Jaypirca matched and improved on Imbruvica across response rates and early progression trends, with safety consistent between treatments.
|
|
Sunday, December 07, 2025 09:32 PM
Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer discussed, along with the tech battleground. A caller asked Cramer about an optimal entry point into the stock, and he replied: “I ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/12/25 | 10.08 | 10.08 | 10.08 | 10.08 | 23,272 |
| 05/12/25 | 9.57 | 9.89 | 9.47 | 9.818 | 171,100 |
| 04/12/25 | 9.41 | 9.829 | 9.41 | 9.76 | 98,700 |
| 03/12/25 | 9.09 | 9.539 | 9.09 | 9.37 | 86,112 |
| 02/12/25 | 9.00 | 9.235 | 8.789 | 9.152 | 168,000 |
| 01/12/25 | 8.72 | 8.976 | 8.54 | 8.942 | 135,900 |
|
|
||||
|
|
||||
|
|